CLEVELAND, July 30, 2008 (PRIME NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced it will present at the Canaccord Adams 28th Annual Global Growth Conference, to be held August 12th - 14th at the Intercontinental Hotel, 510 Atlantic Avenue, Boston, MA.
Gil Van Bokkelen, Chairman and Chief Executive, and William (BJ) Lehmann, President and Chief Operating Officer, will present on Tuesday, August 12th at 4:00 PM EDT. A live audio web cast will be available at: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=ATHX&item_id=1911807, after which time the presentation will be archived for 14 days.
About Athersys, Inc.
Athersys is a biopharmaceutical Company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. In addition to its lead product candidate for the treatment of obesity, ATHX-105, the Company is developing other orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders. Athersys is also developing MultiStem(r), a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications.
The Athersys, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=4548